Top Markets
#1 MowCat MowCat +48.87%
#2 Velvet Velvet +25.75%
#3 Quack AI Quack AI +21.37%
#4 Derive Derive +19.45%
#5 SkyAI SkyAI +17.12%
#6 Bermuda Shorts Bermuda Shorts +15.70%
#7 Geodnet Geodnet +15.17%
#8 aPriori aPriori +11.70%
#9 Cross Cross +11.69%
#10 Audiera Audiera +11.35%
Coin of the day
MowCat MowCat
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.

AzurRx BioPharma, Inc.

AZRX
Classement en actions #35193
AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12... AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).
Prix de l'action
$3.45
Dernière synchronisation: 2021-09-21
Capitalisation boursière
$4.29M
Changement (1 jour)
2.07%
Changement (1 an)
0.00%
Pays
US
Échange AzurRx BioPharma, Inc. (AZRX)

Catégorie

Healthcare
Le prix AZRX avec la capitalisation boursière de B
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
AZRX
$3.45
Capitalisation boursière de AzurRx BioPharma, Inc.(AZRX)
Capitalisation boursière: $4.29M
En August 2026, AzurRx BioPharma, Inc. a une capitalisation boursière de $4.29M. Cela fait de AzurRx BioPharma, Inc. la 35193rd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de AzurRx BioPharma, Inc. du 2016 au 2026
AZRX par rapport au top 5 des plus populaires stocks
Prix pour AZRX L’actif B La capitalisation boursière de B Résultats
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
$4,379,750 $4.29M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +126,949,164.32%
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
$3,607,051 $4.29M
Apple Inc. Apple Inc.
AAPL
$4.490T +104,552,098.46%
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
$3,343,863 $4.29M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +96,923,474.57%
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
$2,953,384 $4.29M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +85,605,235.80%
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
$2,275,920 $4.29M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +65,968,609.20%